Iindaba

I-Alpha Lifetech Incorporation yenza iinguqu kwinkalo ye-biotechnology ngokunikezela ngeenkonzo ezibanzi phezulu nezisezantsi ezilungiselelwe iiproteni eziphinda zisebenze. Ngokugxila ekunikezeni izibonelelo zeprotheyini ezikumgangatho ophezulu, i-Alpha Lifetech ijolise ekulungelelaniseni iinkqubo zophando kunye nophuhliso lweenkampani ze-biopharmaceutical. Ngokubonelela ngezisombululo ezintsha ezihlangabezana neemfuno ezikhethekileyo zeshishini, inkampani iqinisekisa imveliso esebenzayo kunye nokucocwa kweeprotheni. Eli nyathelo lomeleza amandla eenzululwazi kunye nabaphandi kunye nokubeka i-Alpha Lifetech njengenkokeli kwicandelo le-biotechnology. Ngokuzibophelela ekuqhubeleni phambili itekhnoloji yeprotheyini, iAlpha Lifetech Incorporation ikulungele ukwenza igalelo elibalulekileyo kwimpumelelo yesayensi kunye nophuhliso lonyango.

I-Alpha Lifetech Incorporation ibhengeze uphononongo olubanzi lokucocwa kweprotheyini, inyathelo elibalulekileyo kwinkqubo yokuvelisa iprotheyini. Uphononongo lunikeza ukuqonda okuphambili kunye namanqaku abalulekileyo kwiimvavanyo ezilandelayo kunye nophando kwintsimi yokuhlanjululwa kweeprotheyini. Olu phononongo kulindeleke ukuba lube negalelo elibonakalayo ekuqhubeleni phambili kwemveliso yeprotheyini kunye nophuhliso lweenjongo ezintsha zonyango. I-Alpha Lifetech Incorporation iyaziwa ngobuchwephesha bayo kwimveliso ye-biopharmaceutical kwaye izibophelele ekuboneleleni izisombululo ezibukhali zokucoca iiprotheyini. Olu hlaziyo lulindeleke ukuba lube nempembelelo enkulu kwishishini kwaye luqinise indawo ye-Alpha Lifetech njengenkokeli kuphando lwe-biopharmaceutical kunye nophuhliso.

Ngomhla we-1 kaJuni, i-2024, kwijenali yezoNxibelelwano lweNdalo, izazinzulu ezivela kwiqela lophando likaBo Li lipapashe inqaku elinesihloko esithi "Indawo ye-postrema neurons mediate interleukin-6 function in cancer cachexia". Eli nqaku lifumanise ukuba ukuphakama okuqhubekayo kwe-interleukin-6 kunokukhokelela ekungasebenzi kakuhle kwengqondo kwaye ekugqibeleni i-cachexia yomhlaza.

NgoJulayi 11, i-2024, iqela labaphandi elikhokelwa nguDkt Judith Sebolt Leopold lenze i-kinase inhibitor MTX-531 enokuthintela i-epidermal growth factor receptor (EGFR) kunye ne-phosphatidylinositol 3-OH kinase (PI3K).

I-Alpha Lifetech's 700+ biosimilar antibodies ijolise kwi-EGFR, TNF-α, VEGF, ukukhawulezisa uphando lwechiza kunye nomgangatho oqinisekisiweyo.

I-Alpha Lifetech ibonelela ngeeproteni zemembrane ezisemgangathweni zokufunyanwa kweziyobisi kunye nokuqonda kweselula, kusetyenziswa ubuchule obuphambili bemveliso.

Fumana iteknoloji ye-nanobody: umboniso wephage, ugonyo, ukuhlolwa, ukhetho, kunye nohlalutyo lwesakhiwo kwi-Alpha Lifetech yokuxilongwa kunye nonyango.